Effect of anti-IL-4, interferon-gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome
Open Access
- 1 October 1993
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 94 (1) , 11-16
- https://doi.org/10.1111/j.1365-2249.1993.tb05969.x
Abstract
Paracoccidioidomycosis is characterized by depressed cellular but enhanced humoral immune responses, which suggests a Th2 type of response to infection. We investigated possible therapeutic roles for anti-IL-4, interferon-gamma (IFN-γ) and/or SCH 42427 (SCH), a new triazole antifungal agent, and their effect on serum IgE levels in a murine model of chronic Paracoccidioides brasiliensis infection. BALB/c mice infected by the pulmonary route were studied with three programmes. The subacute model and one acute model experiment investigated cytokine secretion by lymph node cells (LNC), and in a second acute experiment mice were given anti-IL-4, IFN-γ or nothing 24 h post infection, then killed at 4 weeks. In the chronic model, mice began treatment at 4 weeks post infection, receiving either SCH, IFN-γ alone, SCH + IFN-γ. or no treatment for 8 weeks. At 2-week intervals lung and spleen burdens of infection and serum polyclonal IgE levels were determined. In the subacute model (non-progressive infection), initially there was dual production of IL-4 and IFN-γ by antigen-stimulated LNC. In the acute progressive infection model IL-4, but not IFN-γ. was secreted. Anti-IL-4 treatment of the acute phase resulted in enhanced host resistance to infection, which correlated with decreased scrum IgE. The chronic model, in which the in vivo efficacy of SCH against P. brasiliensis was shown, suggests possible synergy between immunomodulation and antimicrobial chemotherapy (IFN-γ and SCH). Decreased organ burdens of infection in the chronic model after treatment with SCH, SCH plus IFN-γ, or anti-IL-4 correlated with decreased serum IgE. These promising novel approaches lo treatment of systemic fungal infections suggest a Th2 type of response to P. brasiliensis infection, which can be reversed with successful therapy.Keywords
This publication has 23 references indexed in Scilit:
- IL-4, IgE, and Interferon-γ Production in Pulmonary Blastomycosis: Comparison in Mice Untreated, Immunized, or Treated with an Antifungal (SCH 39304)Cellular Immunology, 1993
- Experimental Antifungal Chemotherapy in Granulocytopenic Animal Models of Disseminated Candidiasis: Approaches to Understanding Investigational Antifungal Compounds for Patients with Neoplastic DiseasesClinical Infectious Diseases, 1992
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The Journal of Experimental Medicine, 1990
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989
- The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype RegulationImmunological Reviews, 1988
- Gamma-interferon activation of macrophages for killing of Paracoccidioides brasiliensis and evidence for nonoxidative mechanismsInternational Journal of Immunopharmacology, 1988
- Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.The Journal of Experimental Medicine, 1987
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985
- Demonstration and Quantification of IgE Antibodies Against Paracoccidioides brasiliensis in ParacoccidioidomycosisInternational Archives of Allergy and Immunology, 1980